Dinh TA - Search Results

1

Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

Dinh TA, Alperin P, Walter LC, Smith R. Dinh TA, et al. J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. J Gen Intern Med. 2012. PMID: 22237663 Free PMC article. Review.

2

Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.

Dinh T, Ladabaum U, Alperin P, Caldwell C, Smith R, Levin TR. Dinh T, et al. Clin Gastroenterol Hepatol. 2013 Sep;11(9):1158-66. doi: 10.1016/j.cgh.2013.03.013. Epub 2013 Mar 28. Clin Gastroenterol Hepatol. 2013. PMID: 23542330

3

Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.

Noah-Vanhoucke J, Green LE, Dinh TA, Alperin P, Smith RA. Noah-Vanhoucke J, et al. Among authors: dinh ta. Cancer. 2011 Aug 1;117(15):3322-31. doi: 10.1002/cncr.25926. Epub 2011 Mar 14. Cancer. 2011. PMID: 21404271 Free article.

4

An estrogen model: the relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk.

Green LE, Dinh TA, Smith RA. Green LE, et al. Among authors: dinh ta. Comput Math Methods Med. 2012;2012:792375. doi: 10.1155/2012/792375. Epub 2012 Jan 16. Comput Math Methods Med. 2012. PMID: 22291855 Free PMC article.

5

Cost-effectiveness of a genetic test for breast cancer risk.

Folse HJ, Green LE, Kress A, Allman R, Dinh TA. Folse HJ, et al. Among authors: dinh ta. Cancer Prev Res (Phila). 2013 Dec;6(12):1328-36. doi: 10.1158/1940-6207.CAPR-13-0056. Cancer Prev Res (Phila). 2013. PMID: 24309564

6

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW. Dinh TA, et al. Cancer Prev Res (Phila). 2011 Jan;4(1):9-22. doi: 10.1158/1940-6207.CAPR-10-0262. Epub 2010 Nov 18. Cancer Prev Res (Phila). 2011. PMID: 21088223 Free PMC article.

7

Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.

Berger BM, Schroy PC 3rd, Dinh TA. Berger BM, et al. Among authors: dinh ta. Clin Colorectal Cancer. 2016 Sep;15(3):e65-74. doi: 10.1016/j.clcc.2015.12.003. Epub 2015 Dec 18. Clin Colorectal Cancer. 2016. PMID: 26792032 Free article.

8

Cost-effectiveness of a genetic test for breast cancer risk--response.

Folse H, Allman R, Dinh TA. Folse H, et al. Among authors: dinh ta. Cancer Prev Res (Phila). 2014 Apr;7(4):476. doi: 10.1158/1940-6207.CAPR-14-0031. Epub 2014 Feb 5. Cancer Prev Res (Phila). 2014. PMID: 24501323 No abstract available.

9

Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.

Redwood DG, Dinh TA, Kisiel JB, Borah BJ, Moriarty JP, Provost EM, Sacco FD, Tiesinga JJ, Ahlquist DA. Redwood DG, et al. Among authors: dinh ta. Mayo Clin Proc. 2021 May;96(5):1203-1217. doi: 10.1016/j.mayocp.2020.07.035. Epub 2021 Apr 9. Mayo Clin Proc. 2021. PMID: 33840520 Free article.

10

The health economics of bladder cancer: an updated review of the published literature.

Yeung C, Dinh T, Lee J. Yeung C, et al. Pharmacoeconomics. 2014 Nov;32(11):1093-104. doi: 10.1007/s40273-014-0194-2. Pharmacoeconomics. 2014. PMID: 25056838 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters